Manganese superoxide dismutase deficiency exacerbates ischemic brain damage under hyperglycemic conditions by

Suresh L Mehta1, Yanling Lin, Wenge Chen

  • 1Department of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, BRITE Building, 302 East Lawson Street, Durham, NC 27707, USA.

Insights

Superoxide dismutase 2 (SOD2) deficiency worsens ischemic brain damage in hyperglycemia by increasing oxidative stress and DNA damage. This exacerbation is linked to suppressed autophagy regulation, highlighting SOD2

Area of Science:

  • Neuroscience
  • Cellular Biology
  • Genetics

Background:

  • Preischemic hyperglycemia and reduced Superoxide Dismutase 2 (SOD2) activity worsen ischemic brain damage.
  • SOD2 plays a crucial role in mitigating oxidative stress within cells.

Purpose of the Study:

  • To investigate the impact of SOD2 mutation on ischemic brain damage in hyperglycemic mice.
  • To explore the relationship between SOD2 deficiency, autophagy regulation, and brain injury under hyperglycemic conditions.

Main Methods:

  • Hyperglycemic wild-type (WT) and heterozygous SOD2 knockout (SOD2(-/+)) mice were subjected to 30-min transient focal ischemia.
  • Brain samples were analyzed post-ischemia for infarct volume, superoxide production, oxidative DNA damage, and levels of autophagy markers (Beclin 1, DRAM, LC3).

Main Results:

  • Hyperglycemic SOD2(-/+) mice exhibited significantly larger infarct volumes compared to WT mice.
  • SOD2(-/+) mice showed early increases in superoxide production and oxidative DNA damage, alongside reduced SOD2 activity.
  • Ischemia suppressed autophagy stimulator levels in hyperglycemic SOD2(-/+) mice, contrasting with increased levels in WT mice.

Conclusions:

  • SOD2 deficiency exacerbates ischemic brain damage in hyperglycemic conditions through enhanced oxidative stress and DNA oxidation.
  • The detrimental effect of SOD2 knockdown is associated with the suppression of key autophagy regulators.

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...